Other languages Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq Other stock markets 01:30:00 30/04/2024 am IST			5-day change	1st Jan Change
58.78 ^USD	-0.12%		-7.48%	-20.55%

17/04	Exact Sciences Corporation announced that it has received $266.75 million in funding	CI
15/04	Sector Update: Health Care Stocks Advance Premarket Monday	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exact Sciences Corporation Announces Executive Changes	15/04
Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes	11/04
Exact Sciences Corp. Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	28/03
Exact Sciences Insider Sold Shares Worth $287,500, According to a Recent SEC Filing	05/03
Exact Sciences Insider Sold Shares Worth $356,302, According to a Recent SEC Filing	29/02
Exact Sciences Insider Sold Shares Worth $305,963, According to a Recent SEC Filing	23/02
Exact Sciences Corporation Provides Earnings Guidance for the first quarter and Year 2024	22/02
Exact Sciences' Q4 Loss Narrows, Revenue Increases; Sets 2024 Revenue Forecast	22/02
Exact Sciences Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Exact Sciences Sees 17% Growth in Q4 Revenue	08/01
Exact Sciences Corporation Provides Revenue Guidance for the Year Ended December 31, 2023 and 2024	08/01
Exact Sciences Corporation Announces Jeff Elliott Plans to Step Down as Executive Vice President	08/01
Exact Sciences Corp. Presents Multiple Studies At San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients	01/12
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy Over Colorectal Cancer Screening Test	17/11
Exact Sciences Q3 EPS, Revenue Increase; Lifts 2023 Revenue Outlook	02/11
Exact Sciences Corporation Raises Revenue Guidance for the Full Year 2023	02/11
Exact Sciences Corporation Appoints Timothy Scannell as Director and Member of Audit and Finance Committee	02/11
Exact Sciences Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
Exact Sciences Corp. Announces Late-Breaking Data from the Pivotal Blue-C Trial	23/23/23
Exact Sciences Insider Sold Shares Worth $864,835, According to a Recent SEC Filing	16/23/16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Exact Sciences Corporation

Equities

EXAS

US30063P1057

Other languages

Filters